U.S. Government to Sponsor CBD Research
CBD is an abbreviated form of Cannabidiol. It is a cannabis compound and accounts for as much as 40% of the extract of the plant. It has several medical benefits and its significant difference from THC is its non-psychoactive effects that do not make people get a feeling of being stoned. This is the reason it has a great appeal among patients commonly suffering from pain, inflammation, seizures, anxiety spasms who desire to get relief without getting the feeling of dysphoria.
The US government is sponsoring several clinical researches, such as the National Institute of Drug Abuse, to measure the potential of CBD for treating different conditions like diabetes, epilepsy, schizophrenia, arthritis, depression and a range of other neuropsychological diseases. A lot of other research centers are also determining the anti-cancer properties of CBD. For medical treatment, it is necessary for the CBD dose to have CBD-dominant strains, that is an increased ratio of CBD as compared to THC.
In simpler terms, if you are using CBD to get “high” on the chemical content, there is no way the compound will be able to respond to that desire however, it can be used for relaxation and giving patients a stress-free feel.